• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Siglec 对巨噬细胞系 RAW264 中 IL-10 表达的影响。

Effects of Siglec on the expression of IL-10 in the macrophage cell line RAW264.

机构信息

Department of Biotechnology, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan.

出版信息

Cytotechnology. 2015 Aug;67(4):633-9. doi: 10.1007/s10616-014-9717-0. Epub 2014 Apr 9.

DOI:10.1007/s10616-014-9717-0
PMID:24715531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4474999/
Abstract

Interleukin-10 (IL-10) expression was significantly elevated upon stimulation with lipopolysaccharide (LPS) when the sialic acid-recognizing Ig-superfamily lectin Siglec-5 or -9 was overexpressed in RAW264 cells. During the course to clarify the mechanism for this activation, we found that IL-10 promoter proximal region up to -500 bp led to transactivation similar to that up to -1,500 bp. Among the transcription factors that activate the mouse IL-10 promoter so far reported, the level of C/EBPβ was increased in Siglec-9-expressing cells. Transient expression of the C/EBPβ major isoform LAP led to an increase in the expression of IL-10 in Siglec-9-expressing cells, but not in mock-transfected control RAW264 cells upon stimulation with LPS, as assessed by either a luciferase assay or the production of IL-10. Without LPS, the IL-10 promoter was activated by transiently expressed LAP in Siglec-9-expressing cells, however, the magnitude of transactivation was less than that with the LPS stimulation. The knockdown of C/EBPβ down-regulated the production of IL-10. Taken together, these results suggest that one of the reasons for the stimulation of IL-10 expression in Siglec-9-expressing cells may be an increase in intracellular C/EBPβ level.

摘要

当 RAW264 细胞中过度表达唾液酸识别 Ig 超家族凝集素 Siglec-5 或 Siglec-9 时,用脂多糖 (LPS) 刺激后白细胞介素 10 (IL-10) 的表达显著升高。在阐明这种激活机制的过程中,我们发现 IL-10 启动子近端区域高达 -500bp 导致与高达 -1500bp 的转录激活相似。迄今为止,在已报道的激活小鼠 IL-10 启动子的转录因子中,Siglec-9 表达细胞中 C/EBPβ 的水平增加。瞬时表达 C/EBPβ 主要同工型 LAP 导致 LPS 刺激时 Siglec-9 表达细胞中 IL-10 的表达增加,但在模拟转染对照 RAW264 细胞中则不然,如通过荧光素酶测定或 IL-10 的产生来评估。没有 LPS 时,IL-10 启动子在 Siglec-9 表达细胞中被瞬时表达的 LAP 激活,但转录激活的幅度小于 LPS 刺激。C/EBPβ 的敲低下调了 IL-10 的产生。综上所述,这些结果表明 Siglec-9 表达细胞中 IL-10 表达的刺激的一个原因可能是细胞内 C/EBPβ 水平的增加。

相似文献

1
Effects of Siglec on the expression of IL-10 in the macrophage cell line RAW264.Siglec 对巨噬细胞系 RAW264 中 IL-10 表达的影响。
Cytotechnology. 2015 Aug;67(4):633-9. doi: 10.1007/s10616-014-9717-0. Epub 2014 Apr 9.
2
Functional cooperation of simian virus 40 promoter factor 1 and CCAAT/enhancer-binding protein beta and delta in lipopolysaccharide-induced gene activation of IL-10 in mouse macrophages.猿猴病毒40启动子因子1与CCAAT/增强子结合蛋白β和δ在脂多糖诱导的小鼠巨噬细胞白细胞介素10基因激活中的功能协作
J Immunol. 2003 Jul 15;171(2):821-8. doi: 10.4049/jimmunol.171.2.821.
3
Siglec-9 modulated IL-4 responses in the macrophage cell line RAW264.唾液酸结合免疫球蛋白样凝集素9(Siglec-9)调节巨噬细胞系RAW264中的白细胞介素-4(IL-4)反应。
Biosci Biotechnol Biochem. 2016;80(3):501-9. doi: 10.1080/09168451.2015.1104238. Epub 2015 Nov 5.
4
Lectin-dependent localization of cell surface sialic acid-binding lectin Siglec-9.依赖凝集素的细胞表面唾液酸结合凝集素 Siglec-9 的定位。
Cytotechnology. 2015 Aug;67(4):601-8. doi: 10.1007/s10616-014-9691-6. Epub 2014 Jan 22.
5
Constitutively expressed Siglec-9 inhibits LPS-induced CCR7, but enhances IL-4-induced CD200R expression in human macrophages.组成性表达的唾液酸结合免疫球蛋白样凝集素-9抑制脂多糖诱导的CCR7,但增强白细胞介素-4诱导的人巨噬细胞中CD200R的表达。
Biosci Biotechnol Biochem. 2016 Jun;80(6):1141-8. doi: 10.1080/09168451.2016.1146070. Epub 2016 Feb 29.
6
Enhanced lentiviral vector production in 293FT cells expressing Siglec-9.表达 Siglec-9 的 293FT 细胞中增强的慢病毒载体生产。
Cytotechnology. 2015 Aug;67(4):593-600. doi: 10.1007/s10616-013-9679-7. Epub 2014 Jan 25.
7
Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs.唾液酸结合免疫球蛋白样凝集素9通过基于酪氨酸的基序增强巨噬细胞中白细胞介素-10的产生。
Biochem Biophys Res Commun. 2008 May 9;369(3):878-83. doi: 10.1016/j.bbrc.2008.02.111. Epub 2008 Mar 4.
8
Involvement of CCAAT enhancer binding protein transcription factors in the regulation of prostaglandin G/H synthase 2 expression by interleukin-1 in osteoblastic MC3T3-E1 cells.CCAAT增强子结合蛋白转录因子参与白细胞介素-1对成骨MC3T3-E1细胞中前列腺素G/H合酶2表达的调控。
J Bone Miner Res. 2000 Jun;15(6):1138-46. doi: 10.1359/jbmr.2000.15.6.1138.
9
NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages.核因子κB和C/EBPβ驱动的白细胞介素-1β基因表达以及PAK1介导的半胱天冬酶-1激活在幽门螺杆菌脂多糖刺激的巨噬细胞释放白细胞介素-1β中起重要作用。
J Biol Chem. 2005 Feb 11;280(6):4279-88. doi: 10.1074/jbc.M412820200. Epub 2004 Nov 23.
10
γ-Tocotrienol inhibits lipopolysaccharide-induced interlukin-6 and granulocyte colony-stimulating factor by suppressing C/EBPβ and NF-κB in macrophages.γ-生育三烯酚通过抑制巨噬细胞中的 C/EBPβ 和 NF-κB 抑制脂多糖诱导的白细胞介素-6 和粒细胞集落刺激因子。
J Nutr Biochem. 2013 Jun;24(6):1146-52. doi: 10.1016/j.jnutbio.2012.08.015. Epub 2012 Dec 15.

引用本文的文献

1
Siglec-9 tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer.Siglec-9 肿瘤相关巨噬细胞在高级别浆液性卵巢癌患者中划定了一个具有治疗脆弱性的免疫抑制亚群。
J Immunother Cancer. 2023 Sep;11(9). doi: 10.1136/jitc-2023-007099.
2
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.Siglec-9 在胶质母细胞瘤的巨噬细胞上作为免疫检查点分子发挥作用,限制 T 细胞的启动和免疫治疗反应。
Nat Cancer. 2023 Sep;4(9):1273-1291. doi: 10.1038/s43018-023-00598-9. Epub 2023 Jul 17.

本文引用的文献

1
Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation.RNA 病毒诱导 Siglec-G 的表达通过促进 RIG-I 的降解来抑制先天免疫反应。
Cell. 2013 Jan 31;152(3):467-78. doi: 10.1016/j.cell.2013.01.011.
2
Dissecting negative regulation of Toll-like receptor signaling.解析 Toll 样受体信号转导的负调控。
Trends Immunol. 2012 Sep;33(9):449-58. doi: 10.1016/j.it.2012.05.002. Epub 2012 Jun 20.
3
CD33-related siglecs as potential modulators of inflammatory responses.CD33 相关的 Siglecs 作为炎症反应的潜在调节剂。
Ann N Y Acad Sci. 2012 Apr;1253:102-11. doi: 10.1111/j.1749-6632.2011.06449.x. Epub 2012 Feb 21.
4
Siglecs and immune regulation.Siglecs 与免疫调节。
Annu Rev Immunol. 2012;30:357-92. doi: 10.1146/annurev-immunol-020711-075018. Epub 2012 Jan 3.
5
The regulation of IL-10 production by immune cells.免疫细胞中 IL-10 产生的调节。
Nat Rev Immunol. 2010 Mar;10(3):170-81. doi: 10.1038/nri2711. Epub 2010 Feb 15.
6
Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production.Siglec-E 在脂多糖刺激后被上调和磷酸化,以限制 TLR 驱动的细胞因子产生。
J Immunol. 2009 Dec 15;183(12):7703-9. doi: 10.4049/jimmunol.0902780.
7
A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair.一种CREB-C/EBPβ级联反应诱导M2巨噬细胞特异性基因表达并促进肌肉损伤修复。
Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17475-80. doi: 10.1073/pnas.0908641106. Epub 2009 Sep 24.
8
Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress.CCAAT/增强子结合蛋白β(C/EBPβ)产物肝脏富集转录激活蛋白(LAP)和肝脏富集转录抑制蛋白(LIP)的差异调控以及内质网应激反应过程中的基因表达调控。
J Biol Chem. 2008 Aug 15;283(33):22443-56. doi: 10.1074/jbc.M801046200. Epub 2008 Jun 11.
9
C/EBPs: recipients of extracellular signals through proteome modulation.C/EBPs:通过蛋白质组调节接收细胞外信号的物质。
Curr Opin Cell Biol. 2008 Apr;20(2):180-5. doi: 10.1016/j.ceb.2008.02.002. Epub 2008 Mar 21.
10
Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs.唾液酸结合免疫球蛋白样凝集素9通过基于酪氨酸的基序增强巨噬细胞中白细胞介素-10的产生。
Biochem Biophys Res Commun. 2008 May 9;369(3):878-83. doi: 10.1016/j.bbrc.2008.02.111. Epub 2008 Mar 4.